Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13
Nov 08, 2017 12:01 pm UTC| Business
REHOVOT, Israel, Nov. 08, 2017 -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it will release financial results for the third...
Quest Resource Welcomes Ric Hobby as Senior Vice President of Sales
Nov 08, 2017 12:01 pm UTC| Business
THE COLONY, Texas, Nov. 08, 2017 -- Quest Resource Holding Corporation (Nasdaq:QRHC) (“Quest”), a leader in sustainability, recycling, and environmental services, announced today that its wholly owned subsidiary, Quest...
Chimerix Announces Third Quarter 2017 Financial Results
Nov 08, 2017 12:01 pm UTC| Business
DURHAM, N.C., Nov. 08, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a corporate update for the...
Nov 08, 2017 12:01 pm UTC| Business
Granted QIDP designation for uncomplicated Urinary Tract Infections (uUTI) by the FDA Highlighted prelaunch activities during Investor Day presentations in October BOSTON, Nov. 08, 2017 -- Paratek Pharmaceuticals,...
Amicus Therapeutics Announces Third Quarter 2017 Financial Results and Corporate Updates
Nov 08, 2017 12:01 pm UTC| Business
260+ Fabry Patients on Reimbursed Galafold™ (Migalastat) and On Target to Reach 300 Patients by Year-End 2017 U.S. NDA Submission for Migalastat Planned in 4Q17 Pompe Retrospective and Prospective Data Collection...
Harsco Corporation Reports Third Quarter 2017 Results
Nov 08, 2017 12:01 pm UTC| Business
Quarterly Revenues Increased 5 Percent Compared with the Prior-Year QuarterQ3 GAAP Operating Income of $34 Million, Including $4.6 Million Bad Debt Expense and an Anticipated Asset Sale Gain of $3.8 Million Q3 Operating...
Neos Therapeutics Reports Third Quarter 2017 Financial Results
Nov 08, 2017 12:00 pm UTC| Business
DALLAS and FORT WORTH, Texas, Nov. 08, 2017 -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...